DRUG PRICING & CHALLENGES TO HEPATITIS C TREATMENT ACCESS.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery.Chemical biology & drug design · 2026
   Review
2. Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study.PLOS global public health · 2025
   Article
3. 340B Participation and Safety Net Engagement Among Federally Qualified Health Centers.JAMA health forum · 2024
   Article
4. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.Microorganisms · 2024
   Review
5. Factors Underlying Racial Disparity in Utilization of Hepatitis C-Viremic Kidneys in the United States.Journal of racial and ethnic health disparities · 2023
   Article
6. Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma.Current oncology (Toronto, Ont.) · 2023
   Review
7. Affordability and Value in Decision Rules for Cost-Effectiveness: A Survey of Health Economists.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022
   Article
8. Morin encapsulated chitosan nanoparticles (MCNPs) ameliorate arsenic induced liver damage through improvement of the antioxidant system and prevention of apoptosis and inflammation in mice.Nanoscale advances · 2022
   Article
9. Value Insider Season 1 Episode 3: How Does Budget Impact and Affordability in Healthcare Work? (BI and Affordability) [Podcast].International journal of general medicine · 2022
   Article
10. Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis.Journal of managed care & specialty pharmacy · 2021
    Article
11. The concept of justifiable healthcare and how big data can help us to achieve it.BMC medical informatics and decision making · 2021
    Review
12. Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2021
    Article
13. Inner Workings: Advances in infectious disease treatment promise to expand the pool of donor organs.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
14. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.PloS one · 2021
    Article
15. A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women.PloS one · 2021
    Article
16. "Sell an Ox" - The Price of Cure for Hepatitis C in Two Countries.International journal of health policy and management · 2020
    Article
17. Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.PloS one · 2020
    Article
18. Coumarin: An emerging antiviral agent.Heliyon · 2020
    Article
19. Emerging trends in modeling human liver diseaseAPL bioengineering · 2019
    Article
20. Issues in the Use of Human Tissues to Support Precision Medicine.Journal of health care for the poor and underserved · 2019
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.